Publications

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
Cancer Res 2017 Oct 17;77(19):5374-5383. Epub 2017 Aug 17.
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.





Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response.
J Immunol 2014 Nov 19;193(9):4654-62. Epub 2014 Sep 19.
Department of Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Graduate Program in Genes and Development, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Graduate Program in Human Molecular Genetics, Center for Stem Cell and Developmental Biology, and Center for Cancer Genetics and Genomics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030





An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.
Blood 2011 Apr 4;117(16):4262-72. Epub 2011 Feb 4.
Section of Transplantation Immunology, Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model.
Cytotherapy 2010 Dec 24;12(8):1056-62. Epub 2010 Aug 24.
Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas, MD Anderson Cancer Center, Unit 900, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal.
PLoS One 2010 Jul 26;5(7):e11770. Epub 2010 Jul 26.
Section of Transplant Immunology, Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.

Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model.
Cancer Microenviron 2010 Mar 19;3(1):83-95. Epub 2010 Mar 19.
Molecular Hematology and Therapy Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 448, Houston, TX 77030-4009 USA.



PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
Cytotherapy 2016 08;18(8):995-1001
Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. Electronic address:





OF